Physicians' Academy for Cardiovascular Education
Member

SGLT2 inhibition in the management of type 2 diabetes: Potential impact on CVD Risk

Prof Silvio E Inzucchi, Yale Diabetes Center, New Haven, CT, USA

Sep. 29, 2015